buprenorphine and Crohn-Disease

buprenorphine has been researched along with Crohn-Disease* in 2 studies

Other Studies

2 other study(ies) available for buprenorphine and Crohn-Disease

Article	Year
Enhanced Metabolism of Buprenorphine in a Man Prescribed Prednisone for Crohn's Disease. The primary care companion for CNS disorders, 2020, 04-23, Volume: 22, Issue:2 Topics: Adult; Buprenorphine; Crohn Disease; Cytochrome P-450 CYP3A; Glucocorticoids; Humans; Male; Narcotics; Opioid-Related Disorders; Prednisone; Substance Abuse Detection; Urinalysis	2020
Buprenorphine for pain relief in a patient with drug abuse. The American journal of drug and alcohol abuse, 1991, Volume: 17, Issue:4 Buprenorphine is a mixed opioid agonist/antagonist which appears to produce less physical dependence and respiratory depression than typical mu-agonist opioids. These effects suggest its use for analgesia for drug abusers. However, buprenorphine may precipitate withdrawal from other opioids. The present case illustrates the utility of buprenorphine and describes a method to transfer a patient from a mu-agonist to buprenorphine without precipitating withdrawal or interrupting analgesia. Topics: Adult; Buprenorphine; Crohn Disease; Drug Administration Schedule; Humans; Male; Morphine; Morphine Dependence; Naloxone; Neurologic Examination; Pain; Pain Measurement; Single-Blind Method; Substance Withdrawal Syndrome	1991

Article

Year

Enhanced Metabolism of Buprenorphine in a Man Prescribed Prednisone for Crohn's Disease.

The primary care companion for CNS disorders, 2020, 04-23, Volume: 22, Issue:2

Topics: Adult; Buprenorphine; Crohn Disease; Cytochrome P-450 CYP3A; Glucocorticoids; Humans; Male; Narcotics; Opioid-Related Disorders; Prednisone; Substance Abuse Detection; Urinalysis

2020

Buprenorphine for pain relief in a patient with drug abuse.

The American journal of drug and alcohol abuse, 1991, Volume: 17, Issue:4

Buprenorphine is a mixed opioid agonist/antagonist which appears to produce less physical dependence and respiratory depression than typical mu-agonist opioids. These effects suggest its use for analgesia for drug abusers. However, buprenorphine may precipitate withdrawal from other opioids. The present case illustrates the utility of buprenorphine and describes a method to transfer a patient from a mu-agonist to buprenorphine without precipitating withdrawal or interrupting analgesia.

Topics: Adult; Buprenorphine; Crohn Disease; Drug Administration Schedule; Humans; Male; Morphine; Morphine Dependence; Naloxone; Neurologic Examination; Pain; Pain Measurement; Single-Blind Method; Substance Withdrawal Syndrome

1991